相关实验视频
Updated: Jun 18, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
在喘中存在唾液IgG对抗eosinophilic炎症蛋白的存在
Rundong Qin1, Fei Long2, Pingan Zhang1
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health; Department of Allergy and Clinical Immunology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Frontiers in immunology
|August 2, 2024
概括
唾液免疫球蛋白G (Sp-IgG) 和其对抗乙氨基蛋白的亚型 (Sp-IgGEPs) 在严重喘中升高,表明自身免疫事件. 一个积极的Sp-IgGEPs签名预测严重的喘,有助于诊断.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 遗传学 遗传学 是一个
背景情况:
- 唾液免疫球蛋白G (Sp-IgG) 诱导了埃索诺菲尔细胞死亡,这表明喘中的自身免疫参与.
- 喘中Sp-IgG的起源和特定亚型需要进一步调查.
研究的目的:
- 探索Sp-IgG在喘中的起源.
- 为了确定与喘中的自身免疫事件相关的Sp-IgG亚型 (Sp-IgGEPs).
- 评估Sp-IgGEPs作为喘严重程度的生物标志物.
主要方法:
- 在165名喘患者和38名对照中测量了Sp-IgG和5个Sp-IgGEPs.
- 根据升高的水平定义了一个积极的Sp-IgGEPs签名 (Sp-IgGEPs+).
- 进行临床分析和门德尔随机化 (MR) 来评估因果关系和风险.
主要成果:
- 在中度/重度喘中,Sp-IgG和Sp-IgGEPs显著更高.
- 升高的Sp-IgGEPs与气道异氨基和Sp-IgG水平相关.
- Sp-IgGEPs+是严重喘的一个独立风险因素 (aOR=5.818).
- 一个结合Sp-IgGEPs+,非过敏状态,低ACT得分和年龄确定的严重喘 (AUC=0.84) 的预测模型.
结论:
- 气道异敏性炎症,Sp-IgG和喘严重程度显著相关.
- Sp-IgGEPs面板可以作为呼吸道自身免疫事件在喘中的特定生物标志物.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Asthma: Pathogenesis and Management
379
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
379
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
386
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
386